Rheumatoid Arthritis
Showing NaN - NaN of 130
Rheumatoid Arthritis Trial in Berlin (VAY736, VAY736 )
Completed
- Rheumatoid Arthritis
- VAY736
- VAY736 placebo
-
Berlin, GermanyNovartis Investigative Site
Dec 9, 2020
Rheumatoid Arthritis Trial in Worldwide (GLPG0634, Placebo)
Rheumatoid Arthritis Trial in Germany, Portugal, Serbia (Certolizumab Pegol, Placebo)
Completed
- Rheumatoid Arthritis
- Certolizumab Pegol
- Placebo
-
Berlin, Germany
- +5 more
Mar 9, 2020
Rheumatoid Arthritis Trial in Worldwide (Anti-TNF-alpha, Methotrexate, Placebo)
Arthritis, Rheumatoid Arthritis Trial in Germany, United States (biological, other, drug)
Completed
- Arthritis
- Rheumatoid Arthritis
- CDP6038
- +4 more
-
Duncansville, Pennsylvania
- +5 more
Jan 17, 2020
Rheumatoid Arthritis Trial in Worldwide (PF-05280586, MabThera, Rituxan)
Completed
- Rheumatoid Arthritis
- PF-05280586
- +2 more
-
Birmingham, Alabama
- +83 more
Oct 30, 2019
Rheumatoid Arthritis Trial in Worldwide (Placebo matched to prednisone, Prednisone, Tocilizumab)
Completed
- Rheumatoid Arthritis
- Placebo matched to prednisone
- +2 more
-
Bordeaux, France
- +38 more
Oct 30, 2019
Rheumatoid Arthritis Trial in Worldwide (Baricitinib, Methotrexate, Baricitinib Placebo)
Rheumatoid Arthritis Trial in Worldwide (ALX-0061, Placebo, Tocilizumab)
Completed
- Rheumatoid Arthritis
- ALX-0061
- +2 more
-
Birmingham, Alabama
- +82 more
Aug 6, 2019
Rheumatoid Arthritis Trial in Worldwide (biological, other, drug)
Completed
- Rheumatoid Arthritis
- ALX-0061
- +2 more
-
Birmingham, Alabama
- +93 more
Aug 6, 2019
Rheumatoid Arthritis Trial in Worldwide (Leflunomide, Methotrexate, Ocrelizumab)
Rheumatoid Arthritis, Musculoskeletal and Connective Tissue Diseases Trial in Worldwide (Adalimumab, Placebo)
Completed
- Rheumatoid Arthritis
- Musculoskeletal and Connective Tissue Diseases
- Adalimumab
- Placebo
-
Tuscaloosa, Alabama
- +69 more
Jun 6, 2019
Enbrel Etanercept Over A Period Of 12 Months In The Routine
Completed
- Rheumatoid Arthritis
- +3 more
-
Dresden, Sachsen, Germany
- +179 more
Mar 29, 2019
Rheumatoid Arthritis Trial in Worldwide (Rituximab-Pfizer (PF-05280586) x 3 courses, Rituximab-EU+ Rituximab-Pfizer x 2 Courses,
Completed
- Rheumatoid Arthritis
- Rituximab-Pfizer (PF-05280586) x 3 courses
- +2 more
-
Birmingham, Alabama
- +70 more
Jan 8, 2019
Rheumatoid Arthritis Trial in Worldwide (PF-06410293, Adalimumab)
Completed
- Rheumatoid Arthritis
- PF-06410293
- Adalimumab
-
Gilbert, Arizona
- +182 more
Jan 18, 2019
Rheumatoid Arthritis Trial in Worldwide (Adalimumab - GP2017, Adalimumab - US licensed Humira)
Completed
- Rheumatoid Arthritis
- Adalimumab - GP2017
- Adalimumab - US licensed Humira
-
Mesa, Arizona
- +82 more
Nov 30, 2018
Rheumatoid Arthritis Trial in Worldwide (Placebo, PF-06651600)
Benepali® PEN Patient Satisfaction Survey
Completed
- Rheumatoid Arthritis
- Spondyloarthropathies
- Benepali
-
Altenholz, Germany
- +37 more
Oct 22, 2018
Safety, Tolerability, Pharmacokinetics Trial in Berlin (AZD9567 Monohydrat, Placebo oral suspension/ Placebo capsule,
Completed
- Safety
- +5 more
- AZD9567 Monohydrat
- +2 more
-
Berlin, GermanyResearch Site
Sep 27, 2018
Rheumatoid Arthritis Trial in Worldwide (Certolizumab Pegol)
Completed
- Rheumatoid Arthritis
- Certolizumab Pegol
-
Huntsville, Alabama
- +60 more
Jul 4, 2018